Ramin Ebrahimi

10.7k citations
164 papers · 5.5k indexed · 4 hit papers · h-index 34
Topics
HIV/AIDS drug development and treatment (27 papers)Atrial Fibrillation Management and Outcomes (17 papers)HIV Research and Treatment (16 papers)

In The Last Decade

Ramin Ebrahimi

153 papers receiving 5.3k citations

Hit Papers

Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockad...20032026201020182003200720072023250500750

Peers

Ramin Ebrahimi
Comparison fields: 5 of 142
  • Cardiology and Cardiovascular Medicine 2.6k
  • Infectious Diseases 1.4k
  • Epidemiology 1.3k
  • Surgery 1.3k
  • Internal Medicine 826
Replace Philimon Gona with:
Philimon Gona United States
Murielle Mary‐Krause France
Matthias Girndt Germany
Priscilla Y. Hsue United States
E Janecek Canada
C Domecq Canada
D Friès Austria
Brent G. Petty United States
Stefan H. Jacobson Sweden
Patrick Commerford South Africa
Ramin Ebrahimi relative to Philimon Gona United States Philimon Gona's profile →
Citations per field
00.5×3.7×
Philimon Gona · 1×
Citations per year

Countries citing papers authored by Ramin Ebrahimi

Since Specialization
Citations

This map shows the geographic impact of Ramin Ebrahimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramin Ebrahimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramin Ebrahimi more than expected).

Fields of papers citing papers by Ramin Ebrahimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramin Ebrahimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramin Ebrahimi. The network helps show where Ramin Ebrahimi may publish in the future.

Co-authorship network of co-authors of Ramin Ebrahimi

This figure shows the co-authorship network connecting the top 25 collaborators of Ramin Ebrahimi. A scholar is included among the top collaborators of Ramin Ebrahimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramin Ebrahimi. Ramin Ebrahimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 3
5 0
6 4
7 2
8 2
9 7
10 11
11 17
12 28
13 2
14 57
15 4
16 5
17 6
18
Abstract 20824: Aged Garlic Extract Supplemented with B Vitamins, Folic Acid and L-Arginine Reduce the Progression of Adipose Tissue and Coronary Artery Calcium
1
19
Impact of the ACUITY and TIMI major bleeding definitions on one-year mortality in patients with acute coronary syndromes
1
20
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ).
440

About Ramin Ebrahimi

Ramin Ebrahimi is a scholar working on Cardiology and Cardiovascular Medicine, Virology and Internal Medicine, having authored 164 papers that have together received 5.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (27 papers), Atrial Fibrillation Management and Outcomes (17 papers) and HIV Research and Treatment (16 papers). The work is most often cited by research in Internal Medicine (826 citations), Cardiology and Cardiovascular Medicine (2.6k citations) and Virology (497 citations). Ramin Ebrahimi has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Frederick Feit, A. Michael Lincoff, Gregg W. Stone, Naser Ahmadi, Roxana Mehran, Fereshteh Hajsadeghi, Matthew J. Budoff, Steven V. Manoukian, Martial Hamon and Jeffrey W. Moses. Their work appears in journals such as JAMA, Circulation and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026